Further stratification of TMA cohort into early stage (TNM stage I/II) and late stage (TNM stage III/IV) revealed that high SCNN1B protein expression is associated with better survival in early (P < 0.05) and late-stage (P < 0.05) CRC (Fig. 1E). Here, SCNN1B is linked to colorectal carcinoma.